| 598 | 0 | 19 |
| 下载次数 | 被引频次 | 阅读次数 |
合成生物技术的快速发展，带来了生物技术产业的空前变革。由于该技术的前沿性、高精尖性、复杂性等特征，其应用也引发了一些伦理争议，如人类安全遭受威胁、社会正义得不到保障、人造生命使“生命”与“非生命”的界限模糊，以及侵犯人类尊严等问题。学界已在解决合成生物技术应用伦理问题的治理原则、政策监管等方面做了有价值的探索，为政府的应对政策和伦理规制提供了理论依据，并且随着研究视野逐渐多元化，充实了现有的理论。然而，研究不足之处在于指导原则比较宽泛抽象，且存在伦理研究的空白区域。“人—非人动物嵌合体伦理问题”“生物样本库知情同意问题”“合成生物技术与人工智能、量子计算结合的伦理问题”等将是未来合成生物技术应用伦理研究的主要方向。
Abstract：The rapid advancement of synthetic biotechnology has triggered unprecedented transformations in the biotechnology industry. However, the cutting-edge, sophisticated, and complex nature of this technology has raised significant ethical controversies, including threats to human security, compromises to social justice, and blurring boundaries between “life” and “non-life” through artificial life creation.Academic efforts have explored governance principles, safety assessments, accountability mechanisms, and policy frameworks to address these ethical challenges, providing theoretical foundations for governmental regulations. While existing research has diversified in scope and enriched current theories, critical gaps remain due to overly abstract guiding principles and unresolved issues such as ethics of human-animal chimeric entities, informed consent in biobanking, ethical implications of integrating synthetic biotechnology with artificial intelligence and quantum computing. These areas represent pivotal directions for future research to ensure ethically aligned development of synthetic biotechnology.
[1]熊燕，陈大明，杨琛，等.合成生物学发展现状与前景[J].生命科学，2011,23(9):826-837.
[2]王国豫，马诗雯，杨君.生命的设计与构建：合成生物学的哲学挑战[J].社会科学战线，2015(2):17-23.
[3]DANIEL YGR.Ethical theory for “Dual-Use” dilemmas in synthetic biology[J].Asian Bioethics Review,2012,4(2):150-159.
[4]GóMEZ-TATAY L,HERNáNDEZ-ANDREU J M.Biosafety and biosecurity in synthetic biology:a review[J].Critical Reviews in Environmental Science and Technology,2019,49(17):1587-1621.
[5]戴聪哲，郝继英.两用生物技术安全风险评估方法研究进展[J].中华医学图书情报杂志，2021,30(10):23-28.
[6]SUN T,SONG J,WANG M,et al.Challenges and recent progress in the governance of biosecurity risks in the era of synthetic biology[J].Journal of Biosafety and Biosecurity,2022,4(1):59-67.
[7]CASES I,DE LORENZO V.Genetically modified organisms for the environment:stories of success and failure and what we have learned from them[J].International Microbiology,2005,8(3):213-222.
[8]WANG F Z,ZHANG W W.Synthetic biology:recent progress,biosafety and biosecurity concerns,and possible solutions[J].Journal of Biosafety and Biosecurity,2019,1(1).
[9]欧亚昆，包珊珊.合成生物学的生物安保问题及其伦理治理建议[J].现代商贸工业，2022,43(16):185-187.
[10]马诗雯，王国豫.如何应对合成生物学的不确定性：《合成生物学的监管：生物砖，生物朋克与生物企业》评介[J].科学与社会，2019,9(3):124-136.
[11]雷瑞鹏，邱仁宗.合成生物学的伦理和治理问题[J].医学与哲学，2019,40(19).
[12]SUNDER MADHAVI.From goods to a good life:intellectual property and global justice[M].New Haven:Yale University Press,2012:30.
[13]KAEBNICK G E,GUSMANO M K,MURRAY T H.The ethics of synthetic biology:next steps and prior questions[J].Hastings Center Report,2014,44(6):4-26.
[14]SAUKSHMYA T,CHUGH A.Commercializing synthetic biology:socio-ethical concerns and challenges under intellectual property regime[J].Journal of Commercial Biotechnology,2010,16(2):135-158.
[15]HENKEL J,MAURER S M.The economics of synthetic biology[J].Molecular Systems Biology,2007(3):117.
[16]TORRANCE A,KAHL L.Bringing standards to life:synthetic biology standards and intellectual property[J].Santa Clara High Technology Law Journal,2013,30(2):199-230.
[17]曾小美，朱泽熙，翁俊.合成生物学产品商业化安全监管思考[J].生物工程学报，2024,40(3):758-772.
[18]ENGELHARD M.Synthetic biology analysed:tools for discussion and evaluation[M].Switzerland:Springer International Publishing,2016:35.
[19]IHDE D.Technics and praxis:a philosophy of technology[M].[S.l.]:D.Reidel Publishing Company,1979:24.
[20]王建红.计算主义的未来：基于科学哲学和SSK的研究[J].哲学动态，2016(6):87-95.
[21]刘晓力.计算主义质疑[J].哲学研究，2003(4):88-94.
[22]JONAS H.The phenomenon of life:toward a philosophical biology[M].Evanston:Northwestern University Press,2001:67.
[23]张慧，闫瑞峰.基因编辑技术与合成生物技术的伦理问题比较[J].科技导报，2022,40(18):56-62.
[24]DABROCK P.Playing God?Synthetic biology as a theological and ethical challenge[J].Systems and Synthetic Biology,2009,3(1):47-54.
[25]张慧，李秋甫，李正风.合成生物学的伦理争论：根源、维度与走向[J].科学学研究，2022,40(4):577-585.
[26]LINK H J.Playing God and the intrinsic value of life:moral problems for synthetic biology?[J].Science and Engineering Ethics,2013,19(2):435-448.
[27]UNESCO.Universal declaration on the human genome and human rights[EB/OL].(1997-11-11)[2025-03-05].https://unesdoc.unesco.org/ark:/48223/pf0000253908.
[28]弗朗西斯·福山.我们的后人类未来——生物技术革命的后果[M].黄立志，译.桂林：广西师范大学出版社，2017:79.
[29]SANDEL M J.The case against perfection:ethics in the age of genetic engineering[M].Cambridge,MA:Harvard University Press,2007:30.
[30]刘晓，熊燕，王方，等.合成生物学伦理、法律与社会问题探讨[J].生命科学，2012,24(11):1334-1338.
[31]杨博文，孙永军.理性赋能与向善赋权：科技伦理风险预警与敏捷治理体系的建构进路[J].科学技术哲学研究，2023,40(4):122-128.
[32]RANDHAWA S,SENGAR S.The evolution and history of gene editing technologies[J].Progress in Molecular Biology and Translational Science,2021(178):1-62.
[33]朱菊隐，展进涛.合成生物学科技风险的管理与规制：国际防范逻辑与中国应对策略[J].科技管理研究，2023,43(10):36-42.
[34]TER M V.Time to settle the synthetic controversy[J].Nature,2014,509(7499):135.
[35]MCLENNAN A.Regulation of synthetic biology:bioBricks,biopunks and bioentrepreneurs[M].Cheltenham:Edward Edgar Publishing,2018:21.
[36]李德新，朱祺.培养皿中的大脑模型：人脑类器官研究的伦理问题探讨[J].自然辩证法通讯，2024,46(4):84-91.
[37]乐晶晶，周学迅，姚海嵩，等.生物样本活库发展现状及伦理问题探讨[J].中国科学：生命科学，2020,50(12):1464-1474.
[38]杨亚军，石宇辉，王国豫.人类生物样本库面临的伦理挑战及应对[J].中国科学：生命科学，2024,54(6):976-986.
[39]庞聪.基因组学时代的知情同意：远离自主，走向信任?[J].自然辩证法通讯，2023,45(1):88-95.
[40]BERA R K.Synthetic biology,artificial intelligence,and quantum computing[M]//NAGPAL M,BOLDURA O,BALT? C,et al.Synthetic Biology-New Interdisciplinary Science.London:IntechOpen,2019,13(1):22-25.
基本信息:
DOI：10.16112/j.cnki.53-1160/c.2025.02.124
中图分类号:Q81-05;B82-057
引用信息:
[1]张京傲红,姜萍.合成生物技术应用的伦理问题研究综述[J].昆明理工大学学报(社会科学版),2025,25(02):69-75.DOI:10.16112/j.cnki.53-1160/c.2025.02.124.
基金信息:
中国工程科技发展战略江苏研究院咨询研究项目“江苏农业生物产业科技创新风险及防范机制研究”(JS2023ZT07)